Comparative affinity of the major genetic variants of human group-specific component (vitamin D-binding protein) for 25-(OH) vitamin D.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Journal of Steroid Biochemistry

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/0022-4731(89)90014-9PMID 2913402
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immune-electrophoretic demonstration of qualitative differences in human sera and their relation to the haptoglobins.

  2009cited by this paper
• Intracellular receptors mediate the biologic action of 1,25-dihydroxyvitamin D3.

  2009cited by this paper
• The polymorphism of the vitamin D-binding protein (Gc); Isoelectric focusing in 3 M urea as additional method for identification of genetic variants

  2004cited by this paper
• Characterization of a monoclonal antibody to human serum vitamin D binding protein (Gc globulin): recognition of an epitope hidden in membranes of circulating monocytes.

  1986cited by this paper
• Group-specific component (vitamin D binding protein) prevents the interaction between G-actin and profilin.

  1986cited by this paper
• Accurate quantitation of native Gc in serum and estimation of endogenous Gc: G-actin complexes by rocket immunoelectrophoresis.

  1985cited by this paper
• Distinct sites on the G-actin molecule bind group-specific component and deoxyribonuclease I.

  1985cited by this paper
• Structural studies of T lymphocyte Fc receptors. Association of Gc protein with IgG binding to Fc gamma.

  1985cited by this paper
• Gc (vitamin D binding protein) binds to cytoplasm of all human lymphocytes and is expressed on B-cell membranes.

  1984cited by this paper
• Electrophoretic demonstration of interactions between group specific component (vitamin D binding protein), actin, and 25‐hydroxycholecalciferol

  1984cited by this paper
• The genetic variants of group-specific component (vitamin D-binding protein) possess different binding characteristics for immobilized Cibacron Blue 3-GA.

  1984cited by this paper
• Linkage between surface immunoglobulin and cytoskeleton of B lymphocytes may involve Gc protein

  1983cited by this paper
• Iron uptake and utilization by mammalian cells. I: Cellular uptake of transferrin and iron

  1983cited by this paper
• A general method for fractionation of plasma proteins. Dye-ligand affinity chromatography on immobilized Cibacron blue F3-GA.

  1982cited by this paper
• Interaction of group-specific component (vitamin D-binding protein) with immobilized Cibacron blue F3-GA.

  1982cited by this paper
• Ultrasensitive stain for proteins in polyacrylamide gels shows regional variation in cerebrospinal fluid proteins.

  1981cited by this paper
• Interpretation of amino acid compositions

  1981cited by this paper
• Binding of the apo and holo forms of the serum vitamin D-binding protein to human lymphocyte cytoplasm and membrane by indirect immunofluorescence.

  1981cited by this paper
• Binding specificity of the rat serum vitamin D transport protein.

  1980cited by this paper
• Vitamin D-binding protein (Gc-globulin) binds actin.

  1980cited by this paper
• Affinity differences for the 25‐OH‐D3 associated with the genetic heterogeneity of the vitamin D‐binding protein

  1980cited by this paper
• Comparative study of the affinity of the serum vitamin D-binding protein.

  1980cited by this paper
• Quantitative studies of the interaction of cholecalciferol ((vitamin D3) and its metabolites with different genetic variants of the serum binding protein for these sterols.

  1979cited by this paper
• Human serum binding protein for vitamin D and its metabolites. II. Specific, high affinity association with a protein in nucleated tissue.

  1979cited by this paper
• Human serum binding protein for vitamin D and its metabolites. I. Physicochemical and immunological identification in human tissues.

  1979cited by this paper
• Binding of 25-hydroxycholecalciferol in tissues.

  1977cited by this paper
• 5 – The Group-Specific Component (Gc) System

  1977cited by this paper
• 25-Hydroxyvitamin D transport in human plasma. Isolation and partial characterization of calcifidiol-binding protein.

  1976cited by this paper
• Measurement of 25-hydroxyvitamin D3 in serum.

  1976cited by this paper
• Sunshine and the geographical distribution of the alleles of the Gc system of plasma proteins

  1976cited by this paper
• Group-specific component (Gc) proteins bind vitamin D and 25-hydroxyvitamin D.

  1975cited by this paper
• Use of plasma-binding proteins for steroid hormone assays.

  1975cited by this paper
• STUDIES ON HUMAN PLASMA α2-MACROGLOBULIN-ENZYME INTERACTIONS

  1973cited by this paper
• 25-Hydroxycholecalciferol-binding globulin in human plasma

  1971cited by this paper
• Zone electrophoresis in starch gels: group variations in the serum proteins of normal human adults.

  1955cited by this paper
• THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS

  1949cited by this paper

• Use of vitamin D binding protein and 25-hydroxyvitamin D levels in clinical practice for endocrinologists.

  2025cites this paper
• Measurement of Serum Free Vitamin D Concentrations: Importance, Challenges, and the Emerging Role of Mass Spectrometry.

  2024cites this paper
• High-Throughput CAMP Assay (HiTCA): A Novel Tool for Evaluating the Vitamin D-Dependent Antimicrobial Response

  2023cites this paper
• GC1f Vitamin D Binding Protein Isoform as a Marker of Severity in Autism Spectrum Disorders

  2022cites this paper
• Vitamin D binding protein/GC‐globulin: a novel regulator of alpha cell function and glucagon secretion

  2021cites this paper
• Total, bioavailable and free 25-hydroxyvitamin D levels as functional indicators for bone parameters in healthy children

  2021cites this paper
• Development and analytical validation of a novel bioavailable 25-hydroxyvitamin D assay

  2021cites this paper
• Alexithymia is associated with reduced vitamin D levels, but not polymorphisms of the vitamin D binding-protein gene

  2021cites this paper
• Opposite correlation of 25-hydroxy-vitamin D- and 1,25-dihydroxy-vitamin D-metabolites with gestational age, bone- and lipid-biomarkers in pregnant women

  2021cites this paper
• New aspects of vitamin D metabolism and action — addressing the skin as source and target

  2020cites this paper
• Posttraumatic stress disorder is associated with reduced vitamin D levels and functional polymorphisms of the vitamin D binding-protein in a population-based sample.

  2020cites this paper
• Structure and function of the vitamin D-binding proteins

  2020cites this paper
• Influence of vitamin D binding protein polymorphism, demographics and lifestyle factors on vitamin D status of healthy Malaysian pregnant women

  2020cites this paper
• Vitamin D levels are associated with trait resilience but not depression in a general population sample

  2020cites this paper
• Prediagnostic Circulating Concentrations of Vitamin D Binding Protein and Survival among Patients with Colorectal Cancer

  2020cites this paper
• Perspective: Vitamin D deficiency and COVID‐19 severity – plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2 and thrombosis

  2020cites this paper
• Vitamin D Binding Protein, Total and Free Vitamin D Levels in Different Physiological and Pathophysiological Conditions

  2019cites this paper
• The GC2 haplotype of the vitamin D binding protein is a risk factor for a low plasma 25-hydroxyvitamin D concentration in a Han Chinese population

  2019cites this paper
• Effect of vitamin D supplementation on total and free 25 hydroxyvitamin D and parathyroid hormone. An analysis of two randomized controlled trials

  2019cites this paper
• Vitamin D Binding Protein and the Biological Activity of Vitamin D

  2019cites this paper
• Allele frequency distribution of SNPs associated with levels of Vitamin D-binding protein and 25-hydroxyvitamin D

  2019cites this paper
• The Vitamin D-Binding Protein

  2018cites this paper
• Vitamin D Assays.

  2018cites this paper
• Ancestry-Adjusted Vitamin D Metabolite Concentrations in Association With Cytochrome P450 3A Polymorphisms

  2018cites this paper
• Determination of Free 25(OH)D Concentrations and Their Relationships to Total 25(OH)D in Multiple Clinical Populations

  2018cites this paper
• Circulating 25‐hydroxyvitamin D, vitamin D binding protein and risk of advanced and lethal prostate cancer

  2018cites this paper
• Low 25-hydroxyvitamin D levels are more prevalent in Canadians of South Asian than European ancestry inhabiting the National Capital Region of Canada

  2018cites this paper
• Free Vitamin D: Concepts, Assays, Outcomes, and Prospects

  2018cites this paper
• Why should we measure free 25(OH) vitamin D?

  2017cites this paper
• Vitamin D metabolites in captivity? Should we measure free or total 25(OH)D to assess vitamin D status?

  2017cites this paper
• Genetic and Racial Differences in the Vitamin D Endocrine System.

  2017cites this paper
• Letter to the Editor: The Effect of Genetic Factors on the Response to Vitamin D Supplementation May Be Mediated by Vitamin D-Binding Protein Concentrations.

  2017cites this paper
• Free or Total 25OHD as Marker for Vitamin D Status?

  2016cites this paper
• Free 25-Hydroxyvitamin D: Impact of Vitamin D Binding Protein Assays on Racial-Genotypic Associations

  2016cites this paper
• Vitamin D binding protein gene polymorphism as a risk factor for vitamin D deficiency in Thais.

  2015cites this paper
• Vitamin D binding protein genotype is associated with plasma 25OHD concentration in West African children

  2015cites this paper
• Accuracy of 6 routine 25-hydroxyvitamin D assays: influence of vitamin D binding protein concentration.

  2012cites this paper
• Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism.

  2006cites this paper
• Plasma concentrations of 25-Hydroxy-Vitamin D and 1,25-Dihydroxy-Vitamin D are Related to the Phenotype of Gc (Vitamin D-Binding Protein): A Cross-sectional Study on 595 Early Postmenopausal Women

  2005cites this paper
• A monoclonal antibody against human vitamin-D-binding protein for the analysis of genetic variation in the group-specific component system (Gc)

  2004cites this paper
• Simple method for determining specific binding capacity of vitamin D-binding protein and its use to calculate the concentration of "free" 1,25-dihydroxyvitamin D.

  1994influential citation
• Elevation of blood vitamin D2 levels does not impede the release of vitamin D3 from the skin.

  1992cites this paper
• The extracellular actin-scavenger system and actin toxicity.

  1992cites this paper
• Interaction of the vitamin D‐binding protein (groupspecific component) and its ligand 25‐hydroxyvitamin D3: Binding differences of the various genetic types disclosed by isoelectric focusing

  1990cites this paper